Fingerprint
Dive into the research topics of 'Safety and convenience of once-weekly somapacitan in adult GH deficiency: A 26-week randomized, controlled trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Safety and convenience of once-weekly somapacitan in adult GH deficiency: A 26-week randomized, controlled trial
Gudmundur Johannsson, Ulla Feldt-Rasmussen, Ida Holme Håkonsson, Henrik Biering, Patrice Rodien, Shigeyuki Tahara, Andrew Toogood, Michael Højby Rasmussen*
*Corresponding author for this work